Get the latest insights, innovation and commentary from Automata experts and external contributors in our lab automation blogs. Discover the impact of lab automation across different workflows and industries, from scaling up ELISA development in drug discovery processes to supercharging CRO labs.
Discover how life sciences face challenges in managing vast, complex data and how automation can enhance data quality, accessibility, compliance, and efficiency, driving innovation and faster discoveries.
Read more
Explore the top five challenges in lab automation and get some practical solutions to overcome them.
Read more
Cloud-first lab automation provides superior benefits to modern labs vs on-site solutions. Find out why in this new article from Automata
Read more
Manual colony counting is repetitive and error-prone, but, with automation, it can be done faster and more accurately
Downtime in drug discovery labs delay an already long and complex process. Here's how to reduce its impact in your lab.
John Vincent, Senior Scientist at Medicines Discovery Catapult, discusses why flexible lab automation is the way forward for drug discovery.
Rapidly developing breakthrough treatments at pace is critical. We investigate the benefits of laboratory automation in early drug discovery.
We sit down with John Vincent, Senior Scientist at Medicines Discovery Catapult, to talk about the benefits of automation in drug discovery
With the reliance on PCR testing set to continue, automation offers an unrivalled opportunity to upscale PCR testing capacity, accuracy and turnaround times.
Despite protections, human error in labs still leads to incorrect diagnostics and exposure to infection. Here’s how automation can prevent these risks.
Investing in lab automation in 2022? Here are the best practices for picking the right lab automation partner
Watch our webinar to learn how the COVID-19 pandemic has empowered labs to meet growing diagnostic demands with automation
Explore the many methods diagnostics labs can employ to improve efficiency in their processes
